Qiagen (QGEN) Liabilities and Shareholders Equity (2009 - 2026)

Qiagen has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $5.8 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $5.8 billion, up 4.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.4 billion (up 5.85% YoY), and the FY2025 annual result was $6.3 billion, up 10.4% from the prior year.
• Liabilities and Shareholders Equity came in at $5.8 billion for Q1 2026 at Qiagen, down from $6.3 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.6 billion in Q3 2025 to a low of $5.5 billion in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $6.2 billion (2022), against an average of $6.1 billion.
• Across the five-year window, Liabilities and Shareholders Equity retreated 12.02% in 2024 and climbed 10.4% in 2025, its largest moves.
• Qiagen's Liabilities and Shareholders Equity stood at $6.3 billion in 2022, then declined by 2.74% to $6.1 billion in 2023, then retreated by 6.96% to $5.7 billion in 2024, then grew by 10.4% to $6.3 billion in 2025, then fell by 7.95% to $5.8 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $5.8 billion (Q1 2026), $6.3 billion (Q4 2025), and $6.6 billion (Q3 2025), per Business Quant data.